Paul Govern Archive — Page 35 of 54
-
March 22, 2018
Grant bolsters study of potential new therapy for C. diff infection
According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis. -
March 1, 2018
Study reveals safety signal from genes that mimic drugs
Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center. -
February 15, 2018
Chren recognized by dermatology academy
Mary-Margaret “Meg” Chren, MD, chair of the Department of Dermatology, is the recipient of the 2018 Clarence S. Livingood, MD, Memorial Award and Lectureship from the American Academy of Dermatology (AAD). -
February 8, 2018
AIDS-defining events increase mortality risk: study
When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. -
February 1, 2018
Study evaluates community-based health efforts
A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension. -
January 25, 2018
Personalized drug prescribing program expands, upgrades
Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.